Corentec Co

Corentec Co Rule of 40

The Rule of 40 of Corentec Co (104540.KQ) as of Oct 16, 2026 is 16.48 %. In the previous year, Rule of 40 was 4.72 % — a change of 249.07% (higher).

Rule of 40

16.48 %

YoY

249.07%

Last updated:

Rule of 40 of Corentec Co is 2025 16.48 % . Rule of 40 of Corentec Co was 2024 4.72 % . It decreases by 249.07% higher compared to the previous year.

The Corentec Co Rule of 40 history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Rule of 40
Date
Rule of 40
Jan 1, 2018
-96.32 KRW
Jan 1, 2019
26.13 KRW
Jan 1, 2020
8.97 KRW
Jan 1, 2021
16.46 KRW
Jan 1, 2022
54.93 KRW
Jan 1, 2023
55.32 KRW
Jan 1, 2024
4.72 KRW
Jan 1, 2025
16.48 KRW
The Corentec Co Rule of 40 history
YEARRule of 40YoY
16.48 %+249.07%
4.72 %-91.47%
55.32 %+0.70%
54.93 %+233.75%
16.46 %+83.50%
8.97 %-65.68%
26.13 %-127.13%
-96.32 %+578.08%
-14.20 %-171.93%
19.75 %+13.73%
17.36 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Corentec Co Stock analysis

What does Corentec Co do? Corentec Co Ltd is a South Korean company headquartered in Cheonan, operating within the Health Care sector. The company went public on March 5, 2013, as indicated by its IPO date. Corentec specializes in the manufacture and sale of artificial articulations, focusing on orthopedic products. Its product portfolio includes hip systems such as primary systems, hemi-arthroplasty systems, and revision systems, featuring cementless and cemented femoral stems, acetabular cups, and bearing systems. The company also offers knee products, comprising primary fixed and mobile type systems, revision knee systems, and augment systems. Additionally, Corentec provides spine products, including pedicle screws and peek cages. The firm markets its hip products under the BENCOX brand, while knee and spine products are sold under the LOSPA and LOSPA IS brand names, respectively. Corentec serves both domestic and international markets, distributing its products globally. The company's website is www.corentec.com. Corentec's business model centers on developing and commercializing orthopedic solutions for joint replacement and spinal care, with a focus on quality and innovation in medical devices. The company's operations are based in Cheonan, South Korea, and it has maintained a presence in the health care industry since its IPO in 2013. Corentec Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Corentec Co stock

Rule of 40 of Corentec Co is 16.48 % in 2025.

On Eulerpool you can find the complete historical development of Rule of 40 Corentec Co since 2006 – with annual values, charts, and detailed analysis.

The Rule of 40 states that a company's revenue growth rate plus profit margin should exceed 40%. It is widely used to evaluate SaaS and high-growth companies.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quality — Corentec Co

All Key Metrics — Corentec Co